fashion -WSS

fashion

author：explore 2025-09-03 14:43:00 - browse：71738

Illustration of a red shopping basket with receipts and bottles and pills. — Adobe

When patients go shopping today, they might find themselves checking out with more than the vitamins or bulk toilet paper on their list. Several retailers have recently launched telehealth programs that let patients pick their medical concern off a menu of options, from hair loss and erectile dysfunction to acne and ear infections. Then they pay cash — no insurance accepted — to have a text or video visit with a provider.

These new virtual care offerings follow efforts by retail giants like Walmart and CVS to build out their health care businesses with a mix of online and brick-and-mortar clinics, some of which accept insurance. But the relative simplicity of operating cash-pay-only, direct-to-consumer virtual care has made it far easier for consumer businesses to jump on the telehealth bandwagon. As more options enter the fray, patients get more choice — and potentially more confusion in an already disjointed health care system.

In late September, Costco announced a partnership with Sesame to offer virtual visits starting at $29 to its members. Later this month, Walgreens will launch its own DTC cash-pay operation, Walgreens Virtual Health, in nine states. And last week, wellness company GNC announced an expansion of its new subscription health plans, which provide unlimited virtual visits for certain conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： NVIDIA and Google execs on the future of AI and drug discovery

explore

WSS

Helping hospitals and community health centers plan for resilience

Military medical care influenced by rank and race, new study finds

HIV vaccine remains elusive. Immunologists keep trying new ideas

Venture capitalist Bob Kocher on the state of digital health

Drug for rare kidney disease narrowly misses mark in clinical trial

Data integrity in scientific journals requires "effort" by publishers, institutions

explore

fashion

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

It's time to retire 'poor historian' from clinicians' vocabularies

Anesthesiologist group: stop taking Ozempic before surgery

Hearing on Medicare drug price negotiation gets unusually heated

Novavax promises a turnaround & Lilly roils the obesity market

CDC's new outbreak response network to include Northeastern

Cancer drug shortages should be causing more outrage

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

After affirmative action ruling, medical educators look to 'holistic review'

FDA panel to weigh approval of NurOwn, controversial ALS drug

explore

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Venture capitalist Bob Kocher on the state of digital health

Medical student insurance fails on mental health care coverage

FDA panel to weigh approval of NurOwn, controversial ALS drug

Military medical care influenced by rank and race, new study finds

Lasker Awards 2023: Winners in biomedical research

hotspot

focus

explore

leisure time